BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 38001542)

  • 21. Mutational impact of APOBEC3A and APOBEC3B in a human cell line and comparisons to breast cancer.
    Carpenter MA; Temiz NA; Ibrahim MA; Jarvis MC; Brown MR; Argyris PP; Brown WL; Starrett GJ; Yee D; Harris RS
    PLoS Genet; 2023 Nov; 19(11):e1011043. PubMed ID: 38033156
    [TBL] [Abstract][Full Text] [Related]  

  • 22. APOBEC3B High Expression in Gastroenteropancreatic Neuroendocrine Neoplasms and Association With Lymph Metastasis.
    Feng C; Zheng Q; Yang Y; Xu M; Lian Y; Huang J; Jiang Y
    Appl Immunohistochem Mol Morphol; 2019 Sep; 27(8):599-605. PubMed ID: 30095460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progressive APOBEC3B mRNA expression in distant breast cancer metastases.
    Sieuwerts AM; Schrijver WA; Dalm SU; de Weerd V; Moelans CB; Ter Hoeve N; van Diest PJ; Martens JW; van Deurzen CH
    PLoS One; 2017; 12(1):e0171343. PubMed ID: 28141868
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence for APOBEC3B mRNA and protein expression in oral squamous cell carcinomas.
    Fanourakis G; Tosios K; Papanikolaou N; Chatzistamou I; Xydous M; Tseleni-Balafouta S; Sklavounou A; Voutsinas GE; Vastardis H
    Exp Mol Pathol; 2016 Dec; 101(3):314-319. PubMed ID: 27818121
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional central polypurine tract provides downstream protection of the human immunodeficiency virus type 1 genome from editing by APOBEC3G and APOBEC3B.
    Wurtzer S; Goubard A; Mammano F; Saragosti S; Lecossier D; Hance AJ; Clavel F
    J Virol; 2006 Apr; 80(7):3679-83. PubMed ID: 16537639
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The DNA deaminase APOBEC3B interacts with the cell-cycle protein CDK4 and disrupts CDK4-mediated nuclear import of Cyclin D1.
    McCann JL; Klein MM; Leland EM; Law EK; Brown WL; Salamango DJ; Harris RS
    J Biol Chem; 2019 Aug; 294(32):12099-12111. PubMed ID: 31217276
    [TBL] [Abstract][Full Text] [Related]  

  • 27. APOBEC3B is expressed in human glioma, and influences cell proliferation and temozolomide resistance.
    Schmitt C; Lucius R; Synowitz M; Held-Feindt J; Hattermann K
    Oncol Rep; 2018 Nov; 40(5):2742-2749. PubMed ID: 30226610
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The surprising activities of APOBEC3B and 5-fluorouracil.
    Walton EL
    Biomed J; 2015; 38(2):97-100. PubMed ID: 25872558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. APOBEC3B regulates R-loops and promotes transcription-associated mutagenesis in cancer.
    McCann JL; Cristini A; Law EK; Lee SY; Tellier M; Carpenter MA; Beghè C; Kim JJ; Sanchez A; Jarvis MC; Stefanovska B; Temiz NA; Bergstrom EN; Salamango DJ; Brown MR; Murphy S; Alexandrov LB; Miller KM; Gromak N; Harris RS
    Nat Genet; 2023 Oct; 55(10):1721-1734. PubMed ID: 37735199
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human APOBEC3B interacts with the heterogenous nuclear ribonucleoprotein A3 in cancer cells.
    Mishra N; Reddy KS; Timilsina U; Gaur D; Gaur R
    J Cell Biochem; 2018 Aug; 119(8):6695-6703. PubMed ID: 29693745
    [TBL] [Abstract][Full Text] [Related]  

  • 31. APOBEC3B is an enzymatic source of molecular alterations in esophageal squamous cell carcinoma.
    Kosumi K; Baba Y; Ishimoto T; Harada K; Nakamura K; Ohuchi M; Kiyozumi Y; Izumi D; Tokunaga R; Taki K; Higashi T; Miyata T; Shigaki H; Kurashige J; Hiyoshi Y; Iwatsuki M; Iwagami S; Sakamoto Y; Miyamoto Y; Yoshida N; Oki E; Watanabe M; Baba H
    Med Oncol; 2016 Mar; 33(3):26. PubMed ID: 26880326
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simian Immunodeficiency Virus Vif and Human APOBEC3B Interactions Resemble Those between HIV-1 Vif and Human APOBEC3G.
    Wang J; Shaban NM; Land AM; Brown WL; Harris RS
    J Virol; 2018 Jun; 92(12):. PubMed ID: 29618650
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The APOBEC3B cytidine deaminase is an adenovirus restriction factor.
    Lejeune N; Mathieu S; Decloux A; Poulain F; Blockx Z; Raymond KA; Willemart K; Vartanian JP; Suspène R; Gillet NA
    PLoS Pathog; 2023 Feb; 19(2):e1011156. PubMed ID: 36745676
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polyomavirus T Antigen Induces
    Starrett GJ; Serebrenik AA; Roelofs PA; McCann JL; Verhalen B; Jarvis MC; Stewart TA; Law EK; Krupp A; Jiang M; Martens JWM; Cahir-McFarland E; Span PN; Harris RS
    mBio; 2019 Feb; 10(1):. PubMed ID: 30723127
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic Polymorphisms Predisposing the Interleukin 6-Induced APOBEC3B-UNG Imbalance Increase HCC Risk via Promoting the Generation of APOBEC-Signature HBV Mutations.
    Liu W; Wu J; Yang F; Ma L; Ni C; Hou X; Wang L; Xu A; Song J; Deng Y; Xian L; Li Z; Wang S; Chen X; Yin J; Han X; Li C; Zhao J; Cao G
    Clin Cancer Res; 2019 Sep; 25(18):5525-5536. PubMed ID: 31152021
    [TBL] [Abstract][Full Text] [Related]  

  • 36. APOBEC3B upregulation and genomic mutation patterns in serous ovarian carcinoma.
    Leonard B; Hart SN; Burns MB; Carpenter MA; Temiz NA; Rathore A; Vogel RI; Nikas JB; Law EK; Brown WL; Li Y; Zhang Y; Maurer MJ; Oberg AL; Cunningham JM; Shridhar V; Bell DA; April C; Bentley D; Bibikova M; Cheetham RK; Fan JB; Grocock R; Humphray S; Kingsbury Z; Peden J; Chien J; Swisher EM; Hartmann LC; Kalli KR; Goode EL; Sicotte H; Kaufmann SH; Harris RS
    Cancer Res; 2013 Dec; 73(24):7222-31. PubMed ID: 24154874
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BE-FLARE: a fluorescent reporter of base editing activity reveals editing characteristics of APOBEC3A and APOBEC3B.
    Coelho MA; Li S; Pane LS; Firth M; Ciotta G; Wrigley JD; Cuomo ME; Maresca M; Taylor BJM
    BMC Biol; 2018 Dec; 16(1):150. PubMed ID: 30593278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular mechanism and clinical impact of APOBEC3B-catalyzed mutagenesis in breast cancer.
    Harris RS
    Breast Cancer Res; 2015 Jan; 17(1):8. PubMed ID: 25848704
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Infection of Bronchial Epithelial Cells by the Human Adenoviruses A12, B3, and C2 Differently Regulates the Innate Antiviral Effector APOBEC3B.
    Lejeune N; Poulain F; Willemart K; Blockx Z; Mathieu S; Gillet NA
    J Virol; 2021 Jun; 95(13):e0241320. PubMed ID: 33853956
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ILF2 enhances the DNA cytosine deaminase activity of tumor mutator APOBEC3B in multiple myeloma cells.
    Kazuma Y; Shirakawa K; Tashiro Y; Yamazaki H; Nomura R; Horisawa Y; Takeuchi S; Stanford E; Konishi Y; Matsui H; Matsumoto T; Tanabe F; Morishita R; Ito S; Takaori-Kondo A
    Sci Rep; 2022 Feb; 12(1):2278. PubMed ID: 35145187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.